Gene: LRP10
Official Full Name: LDL receptor related protein 10provided by HGNC
Gene Summary: This gene encodes a low density lipoprotein receptor family protein. A similar protein in mouse is thought to play a role in the uptake of apolipoprotein E-containing lipoproteins. [provided by RefSeq, Jul 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28471 | LRP10 Knockout cell line (HeLa) | Human | LRP10 | 1:3~1:6 | Negative | Online Inquiry |
KO28472 | LRP10 Knockout cell line (HCT 116) | Human | LRP10 | 1:2~1:4 | Negative | Online Inquiry |
KO28473 | LRP10 Knockout cell line (HEK293) | Human | LRP10 | 1:3~1:6 | Negative | Online Inquiry |
KO28474 | LRP10 Knockout cell line (A549) | Human | LRP10 | 1:3~1:4 | Negative | Online Inquiry |
LRP10 Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology designed to facilitate functional studies of the LRP10 gene, which is implicated in various cellular processes and disease mechanisms. These genetically modified cell lines are derived through precise gene-editing technologies, such as CRISPR-Cas9, which enable the ablation of the LRP10 gene. This knockout approach allows researchers to investigate the role of LRP10 in cellular pathways, its involvement in physiological and pathological conditions, and its potential as a therapeutic target.
The primary mechanism behind these cell lines relies on the disruption of the LRP10 gene, leading to the loss of its protein product. This loss provides an essential model for studying gene function and elucidating the biological consequences of LRP10 deficiency. The ability to observe changes in cellular behavior, signaling pathways, and gene expression profiles in these knockout models is vital for understanding the intricate roles that LRP10 plays in various biological contexts.
Scientifically, LRP10 Gene Knockout Cell Lines are invaluable for both research and clinical applications. In research settings, these cell lines aid in the exploration of disease mechanisms, drug responses, and the development of targeted therapies. They can also be utilized in high-throughput screening assays to identify compounds that may rectify the functional deficits associated with LRP10 deficiencies. Clinically, insights gained from utilizing these cell lines can propel advancements in precision medicine and tailored therapeutic approaches.
What sets LRP10 Gene Knockout Cell Lines apart from alternative products is their superior reliability and specificity. The use of advanced gene-editing techniques ensures a high degree of efficacy in gene knockout, producing homogenous cell populations that maintain stability over multiple passages. Furthermore, our product undergoes rigorous quality control measures to guarantee optimal performance in experimental procedures.
Ultimately, LRP10 Gene Knockout Cell Lines provide researchers and clinicians with a robust platform for innovative exploration and therapeutic development. By employing these vital tools, users can unlock new insights that lead to meaningful breakthroughs in understanding and treating complex diseases. Our company is committed to delivering state-of-the-art biological research products, backed by years of expertise and a dedication to advancing the life sciences industry.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.